Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2020 - 2026)

Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 36.44 Bn 32.71 Bn 1.97 Bn 8.16%
2 Zoetis 33.18 Bn 31.24 Bn 1.62 Bn 26.15%
3 United Therapeutics 23.36 Bn 21.20 Bn 648.10 Mn 75.05%
4 Neurocrine Biosciences 15.90 Bn 14.58 Bn 800.70 Mn -129.09%
5 Aurora Cannabis 15.07 Bn 14.99 Bn 21.72 Mn -
6 Elanco Animal Health 12.06 Bn 11.63 Bn 785.00 Mn -2.94%
7 Hims & Hers Health 8.09 Bn 7.34 Bn 396.79 Mn -55.44%
8 Alkermes 7.47 Bn 6.96 Bn -116.06 Mn -212.48%
9 Lantheus Holdings 6.69 Bn 6.19 Bn 230.92 Mn 37.22%
10 Liquidia 6.26 Bn 6.03 Bn 121.79 Mn -98.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 8.16%
Dec 31, 2025 -0.60%
Sep 30, 2025 -2.80%
Jun 30, 2025 9.65%
Mar 31, 2025 7.68%
Dec 31, 2024 -6.36%
Sep 30, 2024 -2.37%
Jun 30, 2024 -28.21%
Mar 31, 2024 -34.31%
Dec 31, 2023 28.76%
Sep 30, 2023 5.43%
Jun 30, 2023 -1.19%
Mar 31, 2023 -10.44%
Dec 31, 2022 -26.90%
Sep 30, 2022 -13.10%
Jun 30, 2022 -25.28%
Mar 31, 2022 -16.04%
Dec 31, 2021 49.25%
Sep 30, 2021 -6.02%
Jun 30, 2021 5.81%